XTL Biopharmaceuticals Ltd. (FRA:H2K2)

XTL Biopharmaceuticals Revenue

XTL Biopharmaceuticals had revenue of $258.50K USD in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to $968.00K. In the year 2024, XTL Biopharmaceuticals had annual revenue of $451.00K.

• Revenue (ttm): $968.00K
• Revenue Growth: n/a
• P/S Ratio: 8.42
• Revenue / Employee: $96.80K
• Employees: 10
• Market Cap: 6.94M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	451.00K	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-